Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02526017
Title Study of FPA008 in Combination With Nivolumab in Patients With Selected Advance Cancers
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Five Prime Therapeutics, Inc.
Age Groups: adult
Covered Countries USA

No variant requirements are available.